Trial
NCT06622668
NTLA-3001 in Adults with Alpha-1 Antitrypsin Deficiency-Associated Lung Disease
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Intellia Therapeutics
Collaborators
—
Condition
Lung Disease
Intervention
Biological NTLA-3001
Why stopped
Clinical trial ITL-3001-CL-101 for the investigational product NTLA-3001 was withdrawn due to prioritization of other Sponsor programs.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-01-17